Literature DB >> 21934059

Evolving research and stakeholder perspectives on pharmacogenomics.

Amber L Beitelshees1, David L Veenstra.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21934059      PMCID： PMC3559013          DOI： 10.1001/jama.2011.1343

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Authors:  M V Relling; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

2.  Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record.

Authors:  Marylyn D Ritchie; Joshua C Denny; Dana C Crawford; Andrea H Ramirez; Justin B Weiner; Jill M Pulley; Melissa A Basford; Kristin Brown-Gentry; Jeffrey R Balser; Daniel R Masys; Jonathan L Haines; Dan M Roden
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

3.  ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.

Authors:  David R Holmes; Gregory J Dehmer; Sanjay Kaul; Dana Leifer; Patrick T O'Gara; C Michael Stein
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

4.  What to expect from the Pharmacogenomics Research Network.

Authors:  R M Long; J M Berg
Journal:  Clin Pharmacol Ther       Date:  2011-03       Impact factor: 6.875

5.  Reengineering translational science: the time is right.

Authors:  Francis S Collins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

6.  Valuing pharmacogenetic testing services: a comparison of patients' and health care professionals' preferences.

Authors:  Katherine Payne; Emily A Fargher; Stephen A Roberts; Karen Tricker; Rachel A Elliott; Julie Ratcliffe; William G Newman
Journal:  Value Health       Date:  2011-01       Impact factor: 5.725

7.  The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Authors:  Steven M Teutsch; Linda A Bradley; Glenn E Palomaki; James E Haddow; Margaret Piper; Ned Calonge; W David Dotson; Michael P Douglas; Alfred O Berg
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

8.  From the bench to bedside: biological and methodology considerations for the future of companion diagnostics in nonsmall cell lung cancer.

Authors:  Anastasios Dimou; Kevin Harrington; Kostas N Syrigos
Journal:  Patholog Res Int       Date:  2011-07-18

Review 9.  American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

Authors:  Carmen J Allegra; J Milburn Jessup; Mark R Somerfield; Stanley R Hamilton; Elizabeth H Hammond; Daniel F Hayes; Pamela K McAllister; Roscoe F Morton; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544
  9 in total
  3 in total

Review 1.  The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

Authors:  Michael Camilleri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-07       Impact factor: 46.802

Review 2.  The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?

Authors:  Mafalda M Dias; Michael J Sorich; Andrew Rowland; Michael D Wiese; Ross A McKinnon
Journal:  Pharm Res       Date:  2017-02-24       Impact factor: 4.200

3.  Looking to the future: incorporating genomic information into disparities research to reduce measurement error and selection bias.

Authors:  Alexandra E Shields; William H Crown
Journal:  Health Serv Res       Date:  2012-04-19       Impact factor: 3.402
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.